Immunology and Microbiology
Glioma Cell
100%
Sirolimus
100%
Apoptosis
100%
Protein Expression
25%
Gene Expression
25%
Cell Death
25%
Cytotoxicity
25%
Promoter Region
25%
Mitochondrial Membrane Potential
25%
Amino Terminal Sequence
25%
Cell Viability
25%
Gene Control
25%
Somatomedin C
25%
Rapamycin-Insensitive Companion of mTOR
25%
Autophagy
25%
Caspase
25%
Neuroscience
MicroRNA
100%
Apoptosis
100%
Mammalian Target of Rapamycin
100%
Temozolomide
100%
Promoter Region
9%
Gene Expression
9%
Mitochondrial Membrane Potential
9%
Reactive Oxygen Species
9%
Caspase 3
9%
Protein Expression
9%
Glioblastoma Multiforme
9%
Insulin-Like Growth Factor 1
9%
Microarrays
9%
Amino Terminal Sequence
9%
Kinase
9%
Cytotoxicity
9%
Cell Viability
9%
Gene Control
9%
Poly ADP Ribose Polymerase
9%
Phosphoinositide-Dependent Kinase-1
9%
Small Untranslated RNA
9%
Rapamycin-Insensitive Companion of mTOR
9%
Autophagy
9%
Cell Death
9%
Alkylating Antineoplastic Agent
9%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Temozolomide
100%
Mammalian Target of Rapamycin
100%
Glioblastoma
18%
Reactive Oxygen Metabolite
9%
Cytotoxicity
9%
Phosphotransferase
9%
Antiinfective Agent
9%
Cell Viability
9%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
9%
Somatomedin C
9%
Small Untranslated RNA
9%
Alkylating Agent
9%
Phosphoinositide Dependent Protein Kinase 1
9%
Rapamycin-Insensitive Companion of mTOR
9%
Caspase 3
9%